JUVENILE MYELOMONOCYTIC LEUKEMIA
Clinical trials for JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough leukemia: major trial matches patients to Cutting-Edge treatments
Disease control Recruiting nowThis study aims to find better treatments for children and young adults whose leukemia has returned or is hard to treat. It screens patients' blood and bone marrow to understand their specific cancer and match them to new, targeted therapy trials. The goal is to control the disea…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New immune cell therapy tested for Tough-to-Treat leukemia relapse
Disease control Recruiting nowThis study is testing a new treatment for adults and teens whose blood cancers like leukemia have come back after a stem cell transplant. The treatment involves giving patients special immune cells, called CIML NK cells, from their original transplant donor, along with a drug cal…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for kids after cancer transplant: fighting deadly infections with Donor's own cells
Disease control Recruiting nowThis study is testing a new method to help patients recover their immune systems faster after a stem cell transplant for leukemia. It involves giving patients a special, filtered portion of their donor's immune cells, aiming to reduce the risk of life-threatening viral and fungal…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Engineered immune cells target Leukemia's return
Disease control Recruiting nowThis early-stage trial is testing a new cell therapy for children and adults whose leukemia has come back or persists after a donor stem cell transplant. Doctors take immune cells (T cells) from the original donor, genetically modify them to better recognize and attack the patien…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC